<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Iyengar PV</submitter><funding>Dutch Research Council (NWO)</funding><funding>Cancer Genomics Centre</funding><funding>H2020 Marie Skłodowska-Curie Actions</funding><funding>Leids Universitair Medisch Centrum</funding><funding>KWF Kankerbestrijding</funding><pagination>1516-1531</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9530648</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(10)</volume><pubmed_abstract>Patients with bladder cancer often have a poor prognosis due to the highly invasive and metastatic characteristics of bladder cancer cells. Epithelial-to-mesenchymal transition (EMT) has been causally linked to bladder cancer invasion. The E3 ubiquitin ligase, tumor necrosis factor receptor-associated factor 4 (TRAF4) has been implicated as a tumor promoter in a wide range of cancers. In contrast, here we show that low TRAF4 expression is associated with poor overall survival in patients with bladder cancer. We show that the TRAF4 gene is epigenetically silenced and that ERK mediates TRAF4 phosphorylation, resulting in lower TRAF4 protein levels in bladder cancer cells. In addition, we demonstrate that TRAF4 is inversely correlated with an EMT gene signature/protein marker expression. Func</pubmed_abstract><journal>Molecular cancer research : MCR</journal><pubmed_title>TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling.</pubmed_title><pmcid>PMC9530648</pmcid><funding_grant_id>016.176.081</funding_grant_id><funding_grant_id>BUIT 2015-7526</funding_grant_id><funding_grant_id>Veni- 016.176.081</funding_grant_id><funding_grant_id>Gisela Thier</funding_grant_id><pubmed_authors>Suriyamurthy S</pubmed_authors><pubmed_authors>Ten Dijke P</pubmed_authors><pubmed_authors>Xie F</pubmed_authors><pubmed_authors>van Dinther M</pubmed_authors><pubmed_authors>Tan TZ</pubmed_authors><pubmed_authors>Mei H</pubmed_authors><pubmed_authors>Verma CS</pubmed_authors><pubmed_authors>Lama D</pubmed_authors><pubmed_authors>Marvin DL</pubmed_authors><pubmed_authors>Iyengar PV</pubmed_authors><pubmed_authors>Zhang L</pubmed_authors><pubmed_authors>Ritsma L</pubmed_authors></additional><is_claimable>false</is_claimable><name>TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling.</name><description>Patients with bladder cancer often have a poor prognosis due to the highly invasive and metastatic characteristics of bladder cancer cells. Epithelial-to-mesenchymal transition (EMT) has been causally linked to bladder cancer invasion. The E3 ubiquitin ligase, tumor necrosis factor receptor-associated factor 4 (TRAF4) has been implicated as a tumor promoter in a wide range of cancers. In contrast, here we show that low TRAF4 expression is associated with poor overall survival in patients with bladder cancer. We show that the TRAF4 gene is epigenetically silenced and that ERK mediates TRAF4 phosphorylation, resulting in lower TRAF4 protein levels in bladder cancer cells. In addition, we demonstrate that TRAF4 is inversely correlated with an EMT gene signature/protein marker expression. Func</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2026-05-27T22:31:09.633Z</modification><creation>2025-02-19T02:37:59.191Z</creation></dates><accession>S-EPMC9530648</accession><cross_references><pubmed>35731212</pubmed><doi>10.1158/1541-7786.MCR-20-1029</doi></cross_references></HashMap>